Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Olatec Therapeutics set to launch dapansutrile Phase 2 trial in Parkinson’s disease Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a journey… byPallavi MadhirajuFebruary 20, 2024